Exposure to toxic cyanobacterial blooms may accelerate fatal outcomes in amyotrophic lateral sclerosis linked to ...

Clinicians surveyed note the benefits of palliative care for people with ALS, along with barriers to its integration into ...

An iPSC-based ALS-on-a-chip model that mimics disease progression and reveals altered glutamate signaling in motor neurons ...

The global amyotrophic lateral sclerosis treatment market is undergoing gradual yet impactful transformation, driven by ...

Cedars-Sinai has created a lifelike model of the mysterious and fatal disease that could help identify a cause of the illness ...

Living close to cyanobacterial harmful algal blooms in U.S. water bodies is associated with increased risk of mortality from ...

Three years after its approval in the U.S., Radicava ORS has been prescribed to more than 13,500 ALS patients, Mitsubishi ...

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic ...

Storied football coach Erik Thompson’s four-year battle with ALS — Amyotrophic Lateral Sclerosis, or commonly known as Lou ...